{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T06:10:03Z","timestamp":1698041403107},"reference-count":10,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,7,11]],"date-time":"2006-07-11T00:00:00Z","timestamp":1152576000000},"content-version":"vor","delay-in-days":6400,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Hematol"],"published-print":{"date-parts":[[1989,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To determine if heat\u2010treated factor IX complex concentrate is as effective as nonheated factor IX complex concentrate for treatment of subjects with hemophilia A and antifactor VIII antibodies (inhibitor patients), we have retrospectively reviewed consecutive home treatment records of ten inhibitor patients who had been receiving nonheat\u2010treated factor IX complex concentrate (NHT\u2010Konyne) and subsequently converted to heat\u2010treated factor complex concentrate (Konyne\u2010HT) when it was licensed in late 1984. Overall, 162 of 284 (57%) separate bleeding episodes treated with NHT\u2010Konyne and 53 of 80 (66.3%) separate bleeding episodes treated with Konyne\u2010HT required only one treatment course of \u223c60\u201075 U\/kg. The distribution of bleeding sites and the absolute factor IX unitage required per treatment episode were similar for both preparations. These data suggest that the percentage of hemophilic inhibitor patients responding to factor IX complex concentrate remains at least 50%, as was reported several years ago in a controlled study, and that inhibitor bypass activity has not altered by heat treatment.<\/jats:p>","DOI":"10.1002\/ajh.2830300105","type":"journal-article","created":{"date-parts":[[2007,2,21]],"date-time":"2007-02-21T11:50:35Z","timestamp":1172058635000},"page":"22-26","source":"Crossref","is-referenced-by-count":0,"title":["Comparative efficacy of nonheated and heat\u2010treated factor IX complex concentrate in treatment of hemophiliacs with inhibitors"],"prefix":"10.1002","volume":"30","author":[{"given":"Richard S.","family":"Schwartz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia P.","family":"Ewing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toni J.","family":"Gorenc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel A.","family":"Spero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,7,11]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0308-2261(21)00070-9","article-title":"Antibodies to blood coagulation factors","volume":"8","author":"Shapiro SS","year":"1979","journal-title":"Clin Haematol"},{"key":"e_1_2_1_3_2","unstructured":"FeketeLF HolstSL PeetoomF De VerberLL: \u201cAuto\u201d\u2010factor IX concentrate: A new therapeutic approach to treatment of hemophilia A patients with inhibitors. Paper presented at the 14th Congress of the International Society of Hematology Sao Paulo Brazil July 16\u201322 1972."},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197407252910402"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(76)80982-1"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(76)81020-7"},{"key":"e_1_2_1_7_2","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1542\/peds.62.5.767","article-title":"Use of prothrombin complex concentrates in hemophiliacs with inhibitors: Clinical and laboratory studies","volume":"62","author":"Buchanan GR","year":"1978","journal-title":"Pediatrics"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1978.02120280075016"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198008213030803"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198109243051301"},{"key":"e_1_2_1_11_2","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1182\/blood.V62.5.1135.1135","article-title":"Autoplex vs. Proplex: A controlled, double\u2010blind study of effectiveness in acute hemarthroses in hemophiliacs with inhibitors to factor VIII","volume":"62","author":"Lusher JM","year":"1983","journal-title":"Blood"}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fajh.2830300105","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.2830300105","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T12:13:08Z","timestamp":1697976788000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.2830300105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1989,1]]}},"alternative-id":["10.1002\/ajh.2830300105"],"URL":"https:\/\/doi.org\/10.1002\/ajh.2830300105","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"value":"0361-8609","type":"print"},{"value":"1096-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,1]]}}}